{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:11:47Z","timestamp":1789009907063,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00277-024-06007-0","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:22:34Z","timestamp":1727184154000},"page":"4437-4447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trans-acting genetic modifiers of clinical severity in heterozygous \u03b2-Thalassemia trait"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9253-6635","authenticated-orcid":false,"given":"Joanna B.","family":"Loh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5002-7719","authenticated-orcid":false,"given":"Jules M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3935-903X","authenticated-orcid":false,"given":"Khaled M.","family":"Musallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-9238","authenticated-orcid":false,"given":"Kevin H. M.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"issue":"8","key":"6007_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/nejmra2021838","volume":"384","author":"AT Taher","year":"2021","unstructured":"Taher AT, Musallam KM, Cappellini MD (2021) \u03b2-Thalassemias. N Engl J Med 384(8):727\u2013743. https:\/\/doi.org\/10.1056\/nejmra2021838","journal-title":"N Engl J Med"},{"issue":"5","key":"6007_CR2","first-page":"649","volume":"90","author":"SL Thein","year":"2005","unstructured":"Thein SL (2005) Genetic modifiers of beta-thalassemia. Haematologica 90(5):649\u2013660","journal-title":"Haematologica"},{"issue":"9","key":"6007_CR3","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/ajh.27006","volume":"98","author":"KM Musallam","year":"2023","unstructured":"Musallam KM, Lombard L, Kistler KD, Arregui M, Gilroy KS, Chamberlain C, Zagadailov E, Ruiz K, Taher AT (2023) Epidemiology of clinically significant forms of alpha- and beta-thalassemia: a global map of evidence and gaps. Am J Hematol 98(9):1436\u20131451. https:\/\/doi.org\/10.1002\/ajh.27006","journal-title":"Am J Hematol"},{"issue":"1","key":"6007_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/nyas.13056","volume":"1368","author":"HY Luo","year":"2016","unstructured":"Luo HY, Chui DHK (2016) Diverse hematological phenotypes of \u03b2-thalassemia carriers. Ann N Y Acad Sci 1368(1):49\u201355. https:\/\/doi.org\/10.1111\/nyas.13056","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"6007_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.hoc.2017.11.003","volume":"32","author":"S Mettananda","year":"2018","unstructured":"Mettananda S, Higgs DR (2018) Molecular basis and genetic modifiers of Thalassemia. Hematol Oncol Clin North Am 32(2):177\u2013191. https:\/\/doi.org\/10.1016\/j.hoc.2017.11.003","journal-title":"Hematol Oncol Clin North Am"},{"key":"6007_CR6","doi-asserted-by":"publisher","unstructured":"Hariharan P, Gorivale M, Sawant P, Mehta P, Nadkarni A (2021) Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine. Sci Rep 11(1). https:\/\/doi.org\/10.1038\/s41598-021-00169-x","DOI":"10.1038\/s41598-021-00169-x"},{"issue":"45","key":"6007_CR7","doi-asserted-by":"publisher","first-page":"e27522","DOI":"10.1097\/md.0000000000027522","volume":"100","author":"T-H Jaing","year":"2021","unstructured":"Jaing T-H, Chang T-Y, Chen S-H, Lin C-W, Wen Y-C, Chiu C-C (2021) Molecular genetics of \u03b2-thalassemia: a narrative review. Medicine 100(45):e27522. https:\/\/doi.org\/10.1097\/md.0000000000027522","journal-title":"Medicine"},{"issue":"12","key":"6007_CR8","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3324\/haematol.13490","volume":"93","author":"HPJ Voon","year":"2008","unstructured":"Voon HPJ, Vadolas J (2008) Controlling -globin: a review of -globin expression and its impact on -thalassemia. Haematologica 93(12):1868\u20131876. https:\/\/doi.org\/10.3324\/haematol.13490","journal-title":"Haematologica"},{"key":"6007_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/373859","volume":"2011","author":"ME Favero","year":"2011","unstructured":"Favero ME, Costa FF (2011) Alpha-hemoglobin-stabilizing protein: an erythroid molecular chaperone. Biochem Res Int 2011:1\u20137. https:\/\/doi.org\/10.1155\/2011\/373859","journal-title":"Biochem Res Int"},{"issue":"3","key":"6007_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12185-019-02806-8","volume":"111","author":"NS Che Yaacob","year":"2020","unstructured":"Che Yaacob NS, Islam MA, Alsaleh H, Ibrahim IK, Hassan R (2020) Alpha-hemoglobin-stabilizing protein (AHSP): a modulatory factor in \u03b2-thalassemia. Int J Hematol 111(3):352\u2013359. https:\/\/doi.org\/10.1007\/s12185-019-02806-8","journal-title":"Int J Hematol"},{"issue":"1","key":"6007_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1196\/annals.1345.013","volume":"1054","author":"MJ Weiss","year":"2005","unstructured":"Weiss MJ, Zhou S, Feng L, Gell DA, Mackay JP, Shi Y, Gow AJ (2005) Role of alpha hemoglobin-stabilizing protein in normal erythropoiesis and \u03b2\u2010Thalassemia. Ann N Y Acad Sci 1054(1):103\u2013117. https:\/\/doi.org\/10.1196\/annals.1345.013","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"6007_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00277-017-2978-x","volume":"96","author":"P Surapolchai","year":"2017","unstructured":"Surapolchai P, Chuansumrit A, Sirachainan N, Kadegasem P, Leung K-C, So C-C (2017) A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H disease. Ann Hematol 96(6):1005\u20131014. https:\/\/doi.org\/10.1007\/s00277-017-2978-x","journal-title":"Ann Hematol"},{"issue":"10","key":"6007_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1172\/JCI21982","volume":"114","author":"Y Kong","year":"2004","unstructured":"Kong Y, Zhou S, Kihm AJ, Katein AM, Yu X, Gell DA, Mackay JP, Adachi K, Foster-Brown L, Louden CS, Gow AJ, Weiss MJ (2004) Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. J Clin Invest 114(10):1457\u20131466. https:\/\/doi.org\/10.1172\/JCI21982","journal-title":"J Clin Invest"},{"key":"6007_CR14","unstructured":"Galanello RPL, Giagu N, Sole G (2003) Abstracts of the American Society of Hematology 45th Annual Meeting. December 6\u20139, 2003. San Diego, California, USA. Blood 102 (11 Pt 2):1b-512b"},{"issue":"2","key":"6007_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ajh.21041","volume":"83","author":"CO Dos Santos","year":"2008","unstructured":"Dos Santos CO, Zhou S, Secolin R, Wang X, Cunha AF, Higgs DR, Kwiatkowski JL, Thein SL, Gallagher PG, Costa FF, Weiss MJ (2008) Population analysis of the alpha hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function. Am J Hematol 83(2):103\u2013108. https:\/\/doi.org\/10.1002\/ajh.21041","journal-title":"Am J Hematol"},{"issue":"5\u20136","key":"6007_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/03630269.2018.1544145","volume":"42","author":"KG Scheps","year":"2018","unstructured":"Scheps KG, Varela V, Targovnik HM (2018) The chaperones involved in Hemoglobin Synthesis take the spotlight: analysis of AHSP in the Argentinean Population and Review of the literature. Hemoglobin 42(5\u20136):310\u2013314. https:\/\/doi.org\/10.1080\/03630269.2018.1544145","journal-title":"Hemoglobin"},{"issue":"11","key":"6007_CR17","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1182\/blood.V104.11.3770.3770","volume":"104","author":"MD Cappellini","year":"2004","unstructured":"Cappellini MD, Refaldi C, Bignamini D, Zanaboni L, Fiorelli G (2004) Molecular Analysis of Alpha Hemoglobin Stabilizing Protein (AHSP) in caucasian patients with different Beta-thalassemia phenotypes. Blood 104(11):3770\u20133770. https:\/\/doi.org\/10.1182\/blood.V104.11.3770.3770","journal-title":"Blood"},{"issue":"2","key":"6007_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bcmd.2010.04.005","volume":"45","author":"Z Wang","year":"2010","unstructured":"Wang Z, Yu W, Li Y, Shang X, Zhang X, Xiong F, Xu X (2010) Analysis of alpha-hemoglobin-stabilizing protein (AHSP) gene as a genetic modifier to the phenotype of beta-thalassemia in Southern China. Blood Cells Mol Dis 45(2):128\u2013132. https:\/\/doi.org\/10.1016\/j.bcmd.2010.04.005","journal-title":"Blood Cells Mol Dis"},{"issue":"9","key":"6007_CR19","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1182\/blood-2003-11-3957","volume":"103","author":"V Viprakasit","year":"2004","unstructured":"Viprakasit V, Tanphaichitr VS, Chinchang W, Sangkla P, Weiss MJ, Higgs DR (2004) Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with beta thalassemia. Blood 103(9):3296\u20133299. https:\/\/doi.org\/10.1182\/blood-2003-11-3957","journal-title":"Blood"},{"issue":"8","key":"6007_CR20","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00277-019-03722-x","volume":"98","author":"R Ray","year":"2019","unstructured":"Ray R, Kalantri SA, Bhattacharjee S, Biswas A, Shahab A, Biswas S, Bhattacharyya M (2019) Association of alpha hemoglobin\u2013stabilizing protein (AHSP) gene mutation and disease severity among HbE\u2014beta thalassemia patients. Ann Hematol 98(8):1827\u20131834. https:\/\/doi.org\/10.1007\/s00277-019-03722-x","journal-title":"Ann Hematol"},{"issue":"7521","key":"6007_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature13614","volume":"514","author":"J-B Arlet","year":"2014","unstructured":"Arlet J-B, Ribeil J-A, Guillem F, Negre O, Hazoume A, Marcion G, Beuzard Y, Dussiot M, Moura IC, Demarest S, De Beauch\u00eane IC, Belaid-Choucair Z, Sevin M, Maciel TT, Auclair C, Leboulch P, Chretien S, Tchertanov L, Baudin-Creuza V, Seigneuric R, Fontenay M, Garrido C, Hermine O, Courtois G (2014) HSP70 sequestration by free \u03b1-globin promotes ineffective erythropoiesis in \u03b2-thalassaemia. Nature 514(7521):242\u2013246. https:\/\/doi.org\/10.1038\/nature13614","journal-title":"Nature"},{"key":"6007_CR22","doi-asserted-by":"publisher","unstructured":"Ghosh A, Garee G, Sweeny EA, Nakamura Y, Stuehr DJ (2018) Hsp90 chaperones hemoglobin maturation in erythroid and nonerythroid cells. Proceedings of the National Academy of Sciences 115 (6):E1117-E1126. https:\/\/doi.org\/10.1073\/pnas.1717993115","DOI":"10.1073\/pnas.1717993115"},{"key":"6007_CR23","doi-asserted-by":"publisher","unstructured":"Achour A, Koopmann T, Castel R, Santen GWE, den Hollander N, Knijnenburg J, Ruivenkamp CAL, Arkesteijn SGJ, Ter Huurne J, Bisoen S, Verschuren M, Vijfhuizen L, Schaap R, Grimbergen A, Slomp J, Traeger-Synodinos J, Vrettou C, Pissard S, Galacteros F, Baas F, Harteveld CL (2020) A new gene associated with a \u03b2-thalassemia phenotype: the observation of variants in SUPT5H. In: Blood, vol 136. vol 15. United States, pp 1789\u20131793. https:\/\/doi.org\/10.1182\/blood.2020005934","DOI":"10.1182\/blood.2020005934"},{"issue":"20","key":"6007_CR24","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.devcel.2023.07.018","volume":"58","author":"DJ Martell","year":"2023","unstructured":"Martell DJ, Merens HE, Caulier A, Fiorini C, Ulirsch JC, Ietswaart R, Choquet K, Graziadei G, Brancaleoni V, Cappellini MD, Scott C, Roberts N, Proven M, Roy NBA, Babbs C, Higgs DR, Sankaran VG, Churchman LS (2023) RNA polymerase II pausing temporally coordinates cell cycle progression and erythroid differentiation. Dev Cell 58(20):2112\u20132127e2114. https:\/\/doi.org\/10.1016\/j.devcel.2023.07.018","journal-title":"Dev Cell"},{"issue":"1","key":"6007_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/ijlh.13959","volume":"45","author":"J Lou","year":"2023","unstructured":"Lou J, Ye Y, Sun M, Zhao Y, Fu Y, Liu Y (2023) A stepwise haematological screening and whole-exome sequencing reveal multiple mutations from SUPT5H causing an elevation of Hb A(2) from a cohort of 47336 individuals. Int J Lab Hematol 45(1):90\u201395. https:\/\/doi.org\/10.1111\/ijlh.13959","journal-title":"Int J Lab Hematol"},{"key":"6007_CR26","doi-asserted-by":"publisher","first-page":"148294","DOI":"10.1016\/j.gene.2024.148294","volume":"908","author":"Z Lin","year":"2024","unstructured":"Lin Z, Liang X, Wei X, Liang G, Zhu D, Xie H, Yan T, Shang X (2024) SUPT5H mutations associated with elevation of Hb A(2) level: identification of two novel variants and literature review. Gene 908:148294. https:\/\/doi.org\/10.1016\/j.gene.2024.148294","journal-title":"Gene"},{"key":"6007_CR27","doi-asserted-by":"publisher","unstructured":"Harteveld CL, Achour A, Fairuz Mohd Hasan NF, Legebeke J, Arkesteijn SJG, Huurne JT, Verschuren M, Bhagwandien-Bisoen S, Schaap R, Vijfhuizen L, Idrissi HE, Babbs C, Higgs DR, Koopmann TT, Vrettou C, Traeger-Synodinos J, Baas F (2024) Loss-of-function variants in SUPT5H as modifying factors in Beta-Thalassemia. Int J Mol Sci 25(16). https:\/\/doi.org\/10.3390\/ijms25168928","DOI":"10.3390\/ijms25168928"},{"issue":"5","key":"6007_CR28","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood.V95.5.1827.004k10_1827_1833","volume":"95","author":"AC Perkins","year":"2000","unstructured":"Perkins AC, Peterson KR, Stamatoyannopoulos G, Witkowska HE, Orkin SH (2000) Fetal expression of a human agamma globin transgene rescues globin chain imbalance but not hemolysis in EKLF null mouse embryos. Blood 95(5):1827\u20131833","journal-title":"Blood"},{"issue":"4","key":"6007_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/biology12040510","volume":"12","author":"R Catapano","year":"2023","unstructured":"Catapano R, Sessa R, Trombetti S, Cesaro E, Russo F, Izzo P, Makis A, Grosso M (2023) Identification and functional analysis of known and new mutations in the transcription factor KLF1 linked with \u03b2-Thalassemia-like phenotypes. Biology 12(4):510. https:\/\/doi.org\/10.3390\/biology12040510","journal-title":"Biology"},{"issue":"15","key":"6007_CR30","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1182\/blood-2016-01-694331","volume":"127","author":"A Perkins","year":"2016","unstructured":"Perkins A, Xu X, Higgs DR, Patrinos GP, Arnaud L, Bieker JJ, Philipsen S (2016) Kr\u00fcppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants. Blood 127(15):1856\u20131862. https:\/\/doi.org\/10.1182\/blood-2016-01-694331","journal-title":"Blood"},{"issue":"9","key":"6007_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/ng.630","volume":"42","author":"J Borg","year":"2010","unstructured":"Borg J, Papadopoulos P, Georgitsi M, Guti\u00e9rrez L, Grech G, Fanis P, Phylactides M, Verkerk AJMH, Van Der Spek PJ, Scerri CA, Cassar W, Galdies R, Van Ijcken W, \u00d6zg\u00fcr Z, Gillemans N, Hou J, Bugeja M, Grosveld FG, Von Lindern M, Felice AE, Patrinos GP, Philipsen S (2010) Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 42(9):801\u2013805. https:\/\/doi.org\/10.1038\/ng.630","journal-title":"Nat Genet"},{"issue":"5","key":"6007_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3324\/haematol.2010.037333","volume":"96","author":"S Satta","year":"2011","unstructured":"Satta S, Perseu L, Moi P, Asunis I, Cabriolu A, Maccioni L, Demartis FR, Manunza L, Cao A, Galanello R (2011) Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin. Haematologica 96(5):767\u2013770. https:\/\/doi.org\/10.3324\/haematol.2010.037333","journal-title":"Haematologica"},{"issue":"5","key":"6007_CR33","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1182\/blood-2014-03-561779","volume":"124","author":"D Liu","year":"2014","unstructured":"Liu D, Zhang X, Yu L, Cai R, Ma X, Zheng C, Zhou Y, Liu Q, Wei X, Lin L, Yan T, Huang J, Mohandas N, An X, Xu X (2014) KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of \u03b2-thalassemia. Blood 124(5):803\u2013811. https:\/\/doi.org\/10.1182\/blood-2014-03-561779","journal-title":"Blood"},{"issue":"6","key":"6007_CR34","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2002-02-0387","volume":"100","author":"C Yu","year":"2002","unstructured":"Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH (2002) X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood 100(6):2040\u20132045. https:\/\/doi.org\/10.1182\/blood-2002-02-0387","journal-title":"Blood"},{"issue":"2","key":"6007_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1182\/blood.V50.2.303.303","volume":"50","author":"AR Thompson","year":"1977","unstructured":"Thompson AR, Wood WG, Stamatoyannopoulos G (1977) X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis. Blood 50(2):303\u2013316","journal-title":"Blood"},{"key":"6007_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14130","author":"N Singh","year":"2023","unstructured":"Singh N, Bhatia P, Jamwal M, Khadwal AR, Chhabra S, Hira JK, Das R, Sharma P (2023) First reported co-occurrence of \u201cGATA1-mutated X-linked thrombocytopenia with thalassemia (XLTT)\u201d with heterozygous \u03b2-thalassemia. Int J Lab Hematol. https:\/\/doi.org\/10.1111\/ijlh.14130","journal-title":"Int J Lab Hematol"},{"issue":"24","key":"6007_CR37","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1093\/hmg\/10.24.2797","volume":"10","author":"V Viprakasit","year":"2001","unstructured":"Viprakasit V, Gibbons RJ, Broughton BC, Tolmie JL, Brown D, Lunt P, Winter RM, Marinoni S, Stefanini M, Brueton L, Lehmann AR, Higgs DR (2001) Mutations in the general transcription factor TFIIH result in beta-thalassaemia in individuals with trichothiodystrophy. Hum Mol Genet 10(24):2797\u20132802. https:\/\/doi.org\/10.1093\/hmg\/10.24.2797","journal-title":"Hum Mol Genet"},{"issue":"4","key":"6007_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ajhg.2016.02.008","volume":"98","author":"C Kuschal","year":"2016","unstructured":"Kuschal C, Botta E, Orioli D, Digiovanna JJ, Seneca S, Keymolen K, Tamura D, Heller E, Khan SG, Caligiuri G, Lanzafame M, Nardo T, Ricotti R, Peverali FA, Stephens R, Zhao Y, Lehmann AR, Baranello L, Levens D, Kraemer KH, Stefanini M (2016) GTF2E2 mutations destabilize the General Transcription Factor Complex TFIIE in individuals with DNA repair-proficient trichothiodystrophy. Am J Hum Genet 98(4):627\u2013642. https:\/\/doi.org\/10.1016\/j.ajhg.2016.02.008","journal-title":"Am J Hum Genet"},{"issue":"12","key":"6007_CR39","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3324\/haematol.2012.072207","volume":"97","author":"A Iolascon","year":"2012","unstructured":"Iolascon A, Esposito MR, Russo R (2012) Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica 97(12):1786\u20131794. https:\/\/doi.org\/10.3324\/haematol.2012.072207","journal-title":"Haematologica"},{"issue":"2","key":"6007_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.bmt.1702764","volume":"27","author":"A Iolascon","year":"2001","unstructured":"Iolascon A, Sabato V, De Mattia D, Locatelli F (2001) Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II). Bone Marrow Transplant 27(2):213\u2013215. https:\/\/doi.org\/10.1038\/sj.bmt.1702764","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"6007_CR41","first-page":"470","volume":"85","author":"A Iolascon","year":"2000","unstructured":"Iolascon A, Servedio V, Carbone R, Totaro A, Carella M, Perrotta S, Wickramasinghe SN, Delaunay J, Heimpel H, Gasparini P (2000) Geographic distribution of CDA-II: did a founder effect operate in Southern Italy? Haematologica 85(5):470\u2013474","journal-title":"Haematologica"},{"issue":"4","key":"6007_CR42","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood.v98.4.1258","volume":"98","author":"A Iolascon","year":"2001","unstructured":"Iolascon A, Delaunay J, Wickramasinghe SN, Perrotta S, Gigante M, Camaschella C (2001) Natural history of congenital dyserythropoietic anemia type II. Blood 98(4):1258\u20131260. https:\/\/doi.org\/10.1182\/blood.v98.4.1258","journal-title":"Blood"},{"issue":"3","key":"6007_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bjh.14256","volume":"175","author":"A Breton","year":"2016","unstructured":"Breton A, Theodorou A, Aktuna S, Sonzogni L, Darling D, Chan L, Menzel S, van der Spek PJ, Swagemakers SM, Grosveld F, Philipsen S, Thein SL (2016) ASH1L (a histone methyltransferase protein) is a novel candidate globin gene regulator revealed by genetic study of an English family with beta-thalassaemia unlinked to the beta-globin locus. Br J Haematol 175(3):525\u2013530. https:\/\/doi.org\/10.1111\/bjh.14256","journal-title":"Br J Haematol"},{"key":"6007_CR44","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1182\/ashsap8.chapter08","volume-title":"American Society of Hematology Self-Assessment Program","author":"M Kuo","year":"2022","unstructured":"Kuo M, Merrill KH, Altman SA, Mandernach JK, Naik MW, Ulrickson RP M (2022) Hemolytic anemias, excluding hemoglobinopathies. American Society of Hematology Self-Assessment Program. American Society of Hematology, Washington, DC, p 0. doi:https:\/\/doi.org\/10.1182\/ashsap8.chapter08"},{"issue":"4","key":"6007_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000204335","volume":"91","author":"CK Li","year":"1994","unstructured":"Li CK, Ng MH, Cheung KL, Lam TK, Shing MM (1994) Interaction of hereditary spherocytosis and alpha thalassaemia: a family study. Acta Haematol 91(4):201\u2013205. https:\/\/doi.org\/10.1159\/000204335","journal-title":"Acta Haematol"},{"key":"6007_CR46","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5579","author":"X Li","year":"2017","unstructured":"Li X, Liao L, Deng X, Huang J, Deng Z, Wei H, Mo W, Lin F (2017) \u03b1\u2013thalassaemia combined with hereditary spherocytosis in the same patient. Experimental Therapeutic Med. https:\/\/doi.org\/10.3892\/etm.2017.5579","journal-title":"Experimental Therapeutic Med"},{"issue":"3","key":"6007_CR47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/08880019809028796","volume":"15","author":"Z Uysal","year":"1998","unstructured":"Uysal Z, Yildirmak Y, Akar N, Ba\u015fak N, Cin \u015e (1998) \u03b1-Thalassemia and Hereditary Spherocytosis in the same patient: the Interaction of two diseases. Pediatr Hematol Oncol 15(3):271\u2013276. https:\/\/doi.org\/10.3109\/08880019809028796","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"6007_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000208960","volume":"39","author":"M Aksoy","year":"1968","unstructured":"Aksoy M, Erdem S (1968) The combination of hereditary spherocytosis and heterozygous beta-thalassaemia. A family study. Acta Haematol 39(3):183\u2013191. https:\/\/doi.org\/10.1159\/000208960","journal-title":"Acta Haematol"},{"issue":"1","key":"6007_CR49","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/16078454.2020.1846874","volume":"25","author":"M Chen","year":"2020","unstructured":"Chen M, Ye Y-P, Liao L, Deng X-L, Qiu Y-L, Lin F-Q (2020) Hereditary spherocytosis overlooked for 7 years in a pediatric patient with \u03b2-thalassemia trait and novel compound heterozygous mutations of SPTA1 gene. Hematology 25(1):438\u2013445. https:\/\/doi.org\/10.1080\/16078454.2020.1846874","journal-title":"Hematology"},{"issue":"3","key":"6007_CR50","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2141.1993.tb03347.x","volume":"85","author":"EMD Giudice","year":"2008","unstructured":"Giudice EMD, Perrotta S, Nobili B, Pinto L, Cutillo L, Iolascon A (2008) Coexistence of hereditary spherocytosis (HS) due to band 3 deficiency and \u03b2-thalassaemia trait: partial correction of HS phenotype. Br J Haematol 85(3):553\u2013557. https:\/\/doi.org\/10.1111\/j.1365-2141.1993.tb03347.x","journal-title":"Br J Haematol"},{"issue":"8","key":"6007_CR51","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/08880010290097431","volume":"19","author":"N Akar","year":"2002","unstructured":"Akar N, G\u00f6k\u00e7e H, (2002) Red blood cell indexes in patients with hereditary spherocytosis and \u03b2-thalassemia combination. Pediatr Hematol Oncol 19(8):569\u2013573. https:\/\/doi.org\/10.1080\/08880010290097431","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"6007_CR52","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/ijlh.12335","volume":"37","author":"MJ King","year":"2015","unstructured":"King MJ, Gar\u00e7on L, Hoyer JD, Iolascon A, Picard V, Stewart G, Bianchi P, Lee SH, Zanella A (2015) ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol 37(3):304\u2013325. https:\/\/doi.org\/10.1111\/ijlh.12335","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"6007_CR53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1365-2141.2002.03338.x","volume":"117","author":"T Maehara","year":"2002","unstructured":"Maehara T, Tsukamoto N, Nojima Y, Karasawa M, Murakami H, Hattori Y, Ideguchi H (2002) Enhanced haemolysis with \u03b2-thalassaemia trait due to the unstable \u03b2 chain variant, Hb Gunma, accompanied by hereditary elliptocytosis due to protein 4\u00b71 deficiency in a Japanese family. Br J Haematol 117(1):193\u2013197. https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03338.x","journal-title":"Br J Haematol"},{"issue":"2","key":"6007_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ajh.2830330209","volume":"33","author":"S Streichman","year":"1990","unstructured":"Streichman S, Herz E, Tatarsky I (1990) Spectrin modifications in a heterozygous case of both hereditary elliptocytosis and \u03b2-thalassemia. Am J Hematol 33(2):123\u2013127. https:\/\/doi.org\/10.1002\/ajh.2830330209","journal-title":"Am J Hematol"},{"issue":"Pt 1","key":"6007_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1042\/bj3500041","volume":"1","author":"LJ Bruce","year":"2000","unstructured":"Bruce LJ, Wrong O, Toye AM, Young MT, Ogle G, Ismail Z, Sinha AK, McMaster P, Hwaihwanje I, Nash GB, Hart S, Lavu E, Palmer R, Othman A, Unwin RJ, Tanner MJ (2000) Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells. Biochem J 350 Pt 1(Pt 1):41\u201351","journal-title":"Biochem J 350 Pt"},{"issue":"6","key":"6007_CR56","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3324\/haematol.2020.268581","volume":"106","author":"AA Lavinya","year":"2020","unstructured":"Lavinya AA, Razali RA, Razak MA, Mohamed R, Moses EJ, Soundararajan M, Bruce LJ, Eswaran J, Yusoff NM (2020) Homozygous southeast Asian ovalocytosis in five live-born neonates. Haematologica 106(6):1758\u20131761. https:\/\/doi.org\/10.3324\/haematol.2020.268581","journal-title":"Haematologica"},{"key":"6007_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bcmd.2016.12.007","volume":"63","author":"Y Chen","year":"2017","unstructured":"Chen Y, Law HY, Tan GP, Ang AL (2017) Concurrent \u03b2-thalassaemia trait and southeast Asian ovalocytosis associated with clinically significant iron loading. Blood Cells Mol Dis 63:25\u201326. https:\/\/doi.org\/10.1016\/j.bcmd.2016.12.007","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"6007_CR58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ajh.20818","volume":"82","author":"G Fucharoen","year":"2007","unstructured":"Fucharoen G, Fucharoen S, Singsanan S, Sanchaisuriya K (2007) Coexistence of southeast Asian ovalocytosis and \u03b2-thalassemia: a molecular and hematological analysis. Am J Hematol 82(5):381\u2013385. https:\/\/doi.org\/10.1002\/ajh.20818","journal-title":"Am J Hematol"},{"issue":"2","key":"6007_CR59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/cge.12128","volume":"85","author":"L Ngouprommin","year":"2014","unstructured":"Ngouprommin L, Sae-Ung N, Fucharoen S, Fucharoen G, Sanchaisuriya K, Jetsrisuparb A (2014) Genetic compound heterozygosity for southeast Asian ovalocytosis and thalassemia in Thailand: prevalence and phenotypic analysis. Clin Genet 85(2):198\u2013200. https:\/\/doi.org\/10.1111\/cge.12128","journal-title":"Clin Genet"},{"issue":"1","key":"6007_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/ajh.24929","volume":"93","author":"I Andolfo","year":"2018","unstructured":"Andolfo I, Russo R, Gambale A, Iolascon A (2018) Hereditary stomatocytosis: an underdiagnosed condition. Am J Hematol 93(1):107\u2013121","journal-title":"Am J Hematol"},{"issue":"12","key":"6007_CR61","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/ajh.25276","volume":"93","author":"I Andolfo","year":"2018","unstructured":"Andolfo I, Russo R, Rosato BE, Manna F, Gambale A, Brugnara C, Iolascon A (2018) Genotype-phenotype correlation and risk stratification in a cohort of 123 hereditary stomatocytosis patients. Am J Hematol 93(12):1509\u20131517","journal-title":"Am J Hematol"},{"issue":"16","key":"6007_CR62","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1182\/blood-2017-05-786004","volume":"130","author":"E Glogowska","year":"2017","unstructured":"Glogowska E, Schneider ER, Maksimova Y, Schulz VP, Lezon-Geyda K, Wu J, Radhakrishnan K, Keel SB, Mahoney D, Freidmann AM, Altura RA, Gracheva EO, Bagriantsev SN, Kalfa TA, Gallagher PG (2017) Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis. Blood 130(16):1845\u20131856. https:\/\/doi.org\/10.1182\/blood-2017-05-786004","journal-title":"Blood"},{"issue":"8","key":"6007_CR63","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3324\/haematol.2018.205328","volume":"104","author":"V Picard","year":"2019","unstructured":"Picard V, Guitton C, Thuret I, Rose C, Bendelac L, Ghazal K, Aguilar-Martinez P, Badens C, Barro C, B\u00e9n\u00e9teau C, Berger C, Cath\u00e9bras P, Deconinck E, Delaunay J, Durand J-M, Firah N, Galact\u00e9ros F, Godeau B, Ja\u00efs X, De Jaureguiberry J-P, Le Stradic C, Lifermann F, Maffre R, Morin G, Perrin J, Proulle V, Ruivard M, Toutain F, Lahary A, Gar\u00e7on L (2019) Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients. Haematologica 104(8):1554\u20131564. https:\/\/doi.org\/10.3324\/haematol.2018.205328","journal-title":"Haematologica"},{"key":"6007_CR64","doi-asserted-by":"publisher","first-page":"102378","DOI":"10.1016\/j.bcmd.2019.102378","volume":"80","author":"K Maciak","year":"2020","unstructured":"Maciak K, Adamowicz-Salach A, Siwicka A, Poznanski J, Urasinski T, Plochocka D, Gora M, Burzynska B (2020) Hereditary xerocytosis - spectrum and clinical manifestations of variants in the PIEZO1 gene, including co-occurrence with a novel \u03b2-globin mutation. Blood Cells Mol Dis 80:102378. https:\/\/doi.org\/10.1016\/j.bcmd.2019.102378","journal-title":"Blood Cells Mol Dis"},{"key":"6007_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2769570","volume":"2017","author":"E Fermo","year":"2017","unstructured":"Fermo E, Vercellati C, Marcello AP, Zaninoni A, Van Wijk R, Mirra N, Curcio C, Cortelezzi A, Zanella A, Barcellini W, Bianchi P (2017) Hereditary Xerocytosis due to mutations in PIEZO1 gene Associated with heterozygous pyruvate kinase Deficiency and Beta-Thalassemia Trait in two unrelated families. Case Rep Hematol 2017:1\u20138. https:\/\/doi.org\/10.1155\/2017\/2769570","journal-title":"Case Rep Hematol"},{"key":"6007_CR66","doi-asserted-by":"publisher","unstructured":"Pinto VM, Russo R, Quintino S, Rosato BE, Marra R, Del Giudice F, Mogni M, Maffei M, Iolascon A, Forni GL, Andolfo I (2023) Coinheritance of PIEZO1 variants and multi-locus red blood cell defects account for the symptomatic phenotype in beta\u2010thalassemia carriers. Am J Hematol 98(6). https:\/\/doi.org\/10.1002\/ajh.26901","DOI":"10.1002\/ajh.26901"},{"issue":"7","key":"6007_CR67","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/genes12070958","volume":"12","author":"I Andolfo","year":"2021","unstructured":"Andolfo I, Martone S, Rosato BE, Marra R, Gambale A, Forni GL, Pinto V, G\u00f6ransson M, Papadopoulou V, Gavillet M, Elalfy M, Panarelli A, Tomaiuolo G, Iolascon A, Russo R (2021) Complex Modes of Inheritance in Hereditary Red Blood Cell disorders: a Case Series Study of 155 patients. Genes 12(7):958. https:\/\/doi.org\/10.3390\/genes12070958","journal-title":"Genes"},{"issue":"9606","key":"6007_CR68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet 371(9606):64\u201374. https:\/\/doi.org\/10.1016\/s0140-6736(08)60073-2","journal-title":"Lancet"},{"issue":"6","key":"6007_CR69","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3109\/03630269.2013.819558","volume":"37","author":"S Pornprasert","year":"2013","unstructured":"Pornprasert S, Phanthong S (2013) Anemia in patients with coinherited thalassemia and glucose-6-phosphate dehydrogenase deficiency. Hemoglobin 37(6):536\u2013543","journal-title":"Hemoglobin"},{"issue":"1","key":"6007_CR70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.hemonc.2017.05.029","volume":"11","author":"J Pengon","year":"2018","unstructured":"Pengon J, Svasti S, Kamchonwongpaisan S, Vattanaviboon P (2018) Hematological parameters and red blood cell morphological abnormality of glucose-6-Phosphate dehydrogenase deficiency co-inherited with thalassemia. Hematol Oncol Stem Cell Ther 11(1):18\u201324. https:\/\/doi.org\/10.1016\/j.hemonc.2017.05.029","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"3","key":"6007_CR71","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.pcl.2018.02.005","volume":"65","author":"RF Grace","year":"2018","unstructured":"Grace RF, Glader B (2018) Red blood cell enzyme disorders. Pediatr Clin North Am 65(3):579\u2013595. https:\/\/doi.org\/10.1016\/j.pcl.2018.02.005","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"6007_CR72","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1182\/blood.V88.7.2761.bloodjournal8872761","volume":"88","author":"DC Rees","year":"1996","unstructured":"Rees DC, Duley J, Simmonds HA, Wonke B, Thein SL, Clegg JB, Weatherall DJ (1996) Interaction of hemoglobin E and pyrimidine 5\u2019 nucleotidase deficiency. Blood 88(7):2761\u20132767","journal-title":"Blood"},{"issue":"6","key":"6007_CR73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1179\/102453308X343536","volume":"13","author":"N Alli","year":"2008","unstructured":"Alli N, Coetzee M, Louw V, van Rensburg B, Rossouw G, Thompson L, Pissard S, Thein SL (2008) Sickle cell disease in a carrier with pyruvate kinase deficiency. Hematology 13(6):369\u2013372","journal-title":"Hematology"},{"issue":"2","key":"6007_CR74","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1365-2141.1997.3703182.x","volume":"99","author":"R Galanello","year":"1997","unstructured":"Galanello R, Perseu L, Melis MA, Cipollina L, Barella S, Giagu N, Turco MP, Maccioni O, Cao A (1997) Hyperbilirubinaemia in heterozygous \u03b2-thalassaemia is related to co\u2010inherited Gilbert\u2019s syndrome. Br J Haematol 99(2):433\u2013436. https:\/\/doi.org\/10.1046\/j.1365-2141.1997.3703182.x","journal-title":"Br J Haematol"},{"issue":"10","key":"6007_CR75","first-page":"1106","volume":"88","author":"C Borgna-Pignatti","year":"2003","unstructured":"Borgna-Pignatti C, Rigon F, Merlo L, Chakrok R, Micciolo R, Perseu L, Galanello R (2003) Thalassemia minor, the Gilbert mutation, and the risk of gallstones. Haematologica 88(10):1106\u20131109","journal-title":"Haematologica"},{"issue":"3","key":"6007_CR76","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1365-2141.2000.02436.x","volume":"111","author":"A Piperno","year":"2000","unstructured":"Piperno A, Mariani R, Arosio C, Vergani A, Bosio S, Fargion S, Sampietro M, Girelli D, Fraquelli M, Conte D, Fiorelli G, Camaschella C (2000) Haemochromatosis in patients with \u03b2-thalassaemia trait. Br J Haematol 111(3):908\u2013914. https:\/\/doi.org\/10.1111\/j.1365-2141.2000.02436.x","journal-title":"Br J Haematol"},{"issue":"8","key":"6007_CR77","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","volume":"114","author":"KV Kowdley","year":"2019","unstructured":"Kowdley KV, Brown KE, Ahn J, Sundaram V (2019) ACG Clinical Guideline: Hereditary Hemochromatosis. Official J Am Coll Gastroenterol | ACG 114(8):1202\u20131218. https:\/\/doi.org\/10.14309\/ajg.0000000000000315","journal-title":"Official J Am Coll Gastroenterol | ACG"},{"issue":"3","key":"6007_CR78","first-page":"242","volume":"87","author":"MA Melis","year":"2002","unstructured":"Melis MA, Cau M, Deidda F, Barella S, Cao A, Galanello R (2002) H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers. Haematologica 87(3):242\u2013245","journal-title":"Haematologica"},{"issue":"1","key":"6007_CR79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/03630269.2011.637148","volume":"36","author":"H L\u00f3pez-Escribano","year":"2012","unstructured":"L\u00f3pez-Escribano H, Ferragut JF, Parera MM, Guix P, Castro JA, Ramon MM, Picornell A (2012) Effect of Co-inheritance of \u03b2-Thalassemia and hemochromatosis mutations on Iron overload. Hemoglobin 36(1):85\u201392. https:\/\/doi.org\/10.3109\/03630269.2011.637148","journal-title":"Hemoglobin"},{"issue":"4","key":"6007_CR80","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0609.2004.00390.x","volume":"74","author":"G Garewal","year":"2005","unstructured":"Garewal G, Das R, Ahluwalia J, Marwaha RK (2005) Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait. Eur J Haematol 74(4):333\u2013336. https:\/\/doi.org\/10.1111\/j.1600-0609.2004.00390.x","journal-title":"Eur J Haematol"},{"issue":"2","key":"6007_CR81","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000105677","volume":"118","author":"S Yamsri","year":"2007","unstructured":"Yamsri S, Sanchaisuriya K, Fucharoen S, Fucharoen G, Jetsrisuparb A, Wiangnon S, Changtrakul Y, Sanchaisuriya P (2007) H63D mutation of the hemochromatosis gene and serum ferritin levels in Thai Thalassemia carriers. Acta Haematol 118(2):99\u2013105. https:\/\/doi.org\/10.1159\/000105677","journal-title":"Acta Haematol"},{"issue":"6","key":"6007_CR82","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1046\/j.0902-4441.2003.00159.x","volume":"71","author":"M Jazayeri","year":"2003","unstructured":"Jazayeri M, Bakayev V, Adibi P, Haghighi Rad F, Zakeri H, Kalantar E, Zali MR (2003) Frequency of HFE gene mutations in Iranian beta-thalassaemia minor patients. Eur J Haematol 71(6):408\u2013411. https:\/\/doi.org\/10.1046\/j.0902-4441.2003.00159.x","journal-title":"Eur J Haematol"},{"issue":"12","key":"6007_CR83","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10038-004-0202-z","volume":"49","author":"R Martins","year":"2004","unstructured":"Martins R, Pican\u00e7o I, Fonseca A, Ferreira L, Rodrigues O, Coelho M, Seixas T, Miranda A, Nunes B, Costa L, Rom\u00e3o L, Faustino P (2004) The role of HFE mutations on iron metabolism in beta-thalassemia carriers. J Hum Genet 49(12):651\u2013655. https:\/\/doi.org\/10.1007\/s10038-004-0202-z","journal-title":"J Hum Genet"},{"issue":"4","key":"6007_CR84","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3934\/molsci.2021018","volume":"8","author":"B Selvaraj","year":"2021","unstructured":"Selvaraj B, Soundararajan S, Narayanasamy S, Subramanian G, Ramanathan SK (2021) Frequency of hereditary hemochromatosis gene mutations and their effects on iron overload among beta thalassemia patients of Chennai residents. AIMS Mol Sci 8(4):233\u2013247. https:\/\/doi.org\/10.3934\/molsci.2021018","journal-title":"AIMS Mol Sci"},{"issue":"6","key":"6007_CR85","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1097\/hs9.0000000000000739","volume":"6","author":"NBA Roy","year":"2022","unstructured":"Roy NBA, Da Costa L, Russo R, Bianchi P, Del Mar Ma\u00f1\u00fa-Pereira M, Fermo E, Andolfo I, Clark B, Proven M, Sanchez M, van Wijk R, van der Zwaag B, Layton M, Rees D, Iolascon A (2022) The Use of Next-generation sequencing in the diagnosis of Rare inherited anaemias: a joint BSH\/EHA good practice paper. Hemasphere 6(6):e739. https:\/\/doi.org\/10.1097\/hs9.0000000000000739","journal-title":"Hemasphere"},{"issue":"9","key":"6007_CR86","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/gim.2013.92","volume":"15","author":"HL Rehm","year":"2013","unstructured":"Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E (2013) ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15(9):733\u2013747. https:\/\/doi.org\/10.1038\/gim.2013.92","journal-title":"Genet Med"},{"issue":"5","key":"6007_CR87","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06007-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T01:05:50Z","timestamp":1730855150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06007-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":87,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["6007"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06007-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}